Fill out the form below to download your copy.
Next Generation Sequencing (NGS) has transformed the life sciences and diagnostics landscapes. This technology is used for applications including human whole genome sequencing (WGS), whole exome sequencing (WES; 1-2% of the genome that encodes proteins), targeted sequencing using panels of a few-to-thousands of genes, and expression profiling (i.e., RNA-Seq). We forecast that the manufacturer market size will reach ~$4.4B in 2019, and grow at 14% p.a. to $6.5B in 2020, driven primarily by adoption from clinical customers worldwide. NGS has revolutionized not only medical research in academic laboratories and biopharma, but also the health care landscape and applied markets (e.g., AgBio, food testing).